UDK: 615.036.8

THE CLINICAL EFFICACY AND SAFETY OF RUSSIAN INFLUENZA VACCINES FOR IMMUNIZATION OFCHILDREN IN VOLGOGRAD

Yu.V. Ponomareva, I.N. Shishimorov, O.V. Magnitskaya, T.V. Plakhotnuk

Волгоградский государственный медицинский университет, Волгоград, Россия

Abstract

Vaccination is recognized as the most effective measure to prevent influenza and its severe outcomes. Purpose of the work: to compare the clinical efficacy and safety of the Ultrix® and Sovigripp® vaccines in healthy schoolchildren in Volgograd. Results: the study included 140 schoolchildren of 7–12 years old, vaccinated with Ultrix® and Sovigripp®. Mild post-vaccination reactions were registered in 4,2 % of cases in the Ultrix® group and in 10 % of participants in the Sovigrippa® group. During the subsequent follow-up period, 74,3 % of children in the Ultrix® group and 64 % in the Sovigripp® group had no cases of SARI.

Keywords

influenza, vaccination, children, respiratory tract infections, efficacy, Sovigripp® vaccine, Ultrix® vaccine

Contacts

Юлия Владимировна Пономарева, ju.ponomareva@gmail.com